Zevex (NASDAQ:ZVXI)
Historical Stock Chart
From Jun 2019 to Jun 2024
ZEVEX International Inc. (Nasdaq: ZVXI) today announced
the European launch of a new robust, lightweight, enteral feeding pump
through its marketing partner, the clinical nutrition division of
Royal Numico, Nutricia Clinical. The Flocare(R) Infinity(TM),
manufactured by ZEVEX, is a private-label version of ZEVEX's new
Infinity enteral feeding pump that provides patients in hospitals,
nursing homes, or at home with the lightest, most accurate, and
longest-lasting, battery-operated pump available in Europe. ZEVEX
began marketing its own EnteraLite(R) Infinity(TM) enteral feeding
pump in the United States in January 2005.
Enteral nutrition, or tube feeding directly into the
gastrointestinal tract, is indicated for patients who cannot maintain
their nutrition needs via normal oral feeding. Patients who benefit
from enteral tube feeding include post-stroke and head and neck trauma
victims, and those with cancer, gastrointestinal and esophageal
disorders.
David J. McNally, CEO and president of ZEVEX, said, "We are
extremely pleased that the Flocare Infinity pump is being introduced
by Nutricia Clinical into key European markets. The superior
performance and benefits of our pump technology will support Nutricia
Clinical's continued market share growth in those markets. This launch
culminates a tremendous amount of collaboration and hard work between
both of our product development and marketing teams.
"Pursuant to our agreements with Royal Numico, ZEVEX is
manufacturing the Flocare Infinity pump, disposable components, and
accessories for distribution by Nutricia Clinical into more than 30
countries outside of North America. Under these agreements, ZEVEX
expects to realize approximately $3.5 million in revenue in 2005 and
$7 million in annual revenue for several years thereafter from the
sale of the Flocare Infinity pump and other products," continued
McNally.
Rudy Mareel, president of Nutricia Clinical, Numico's clinical
nutrition division, said, "I am delighted to be able to add this
industry-leading Flocare pump to our complete enteral care package.
The first priority of Nutricia Clinical has always been to offer the
most flexible solutions while paying the most rigorous attention to
safety.
"Our Nutrison Pack offers the most flexible packaging format for
specialized clinical nutrition. Our feeding tubes in DEHP-free plastic
lead the competition in this important safety area. We will market the
Flocare Infinity pump as an integral component of our total tube feed
offering. We are confident of rapid success, and we look forward to a
strong and lasting relationship with our partners at ZEVEX," continued
Mareel.
Patented ZEVEX technology removes barriers to portability and
ease of use that are commonly faced by enteral nutrition patients.
Because the new Flocare Infinity pump includes a 24-hour battery and
weighs just 14.4 ounces (408 grams), Flocare patients can be mobile
and feed at any place or time. The Flocare Infinity's keypad and
display are easy for patients and caregivers to understand and use.
Its feature set includes the widest flow-rate range and largest
display text of any enteral pump, and it is the only pump on the
market that can be cleaned under running water. The engineering
breakthrough for cleaning the pump addresses a need expressed by
caregivers to easily maintain the pump without fear of damage.
Patented ZEVEX sensing technology also allows the pump to operate
without annual calibration of pump sensors, further reducing the cost
of ownership. The Flocare Infinity's versatility makes it well-suited
for use by patients of all ages in hospitals, nursing homes or at
home.
About ZEVEX International Inc.
ZEVEX International Inc. (www.zevex.com), founded in 1986,
transforms life with its patented and proprietary medical device
technologies. The Therapeutics division manufactures and markets
enteral nutrition delivery devices. The Applied Technology division
designs and manufactures advanced medical components and systems for
medical technology companies.
About Royal Numico N.V.
Royal Numico N.V. (www.numico.com) is a specialized nutrition
company with leading positions in baby food and clinical nutrition,
with annual revenue of almost $2.0 billion. The company operates in
more than 100 countries and employs approximately 11,000 people.
Nutricia Clinical, Numico's clinical nutrition division, holds leading
market positions for clinical nutrition products in Europe and other
key markets and generated more than $600 million in revenue in 2004.
Forward-Looking Statements
Statements made in this press release, including those relating to
anticipated revenue growth and other statements regarding future
performance, are forward looking and are made pursuant to the safe
harbor provisions of the Securities Litigation Reform Act of 1995.
Such statements involve risks and uncertainties that may cause actual
results to differ materially from those set forth in these statements.
Among other things, the company's efforts to increase its sales could
be more difficult or expensive than the company currently anticipates.
Specifically, the agreements between Royal Numico and ZEVEX may not
produce projected sales growth. In addition to the foregoing, the
economic, competitive, governmental, technological and other factors
identified in the company's filings with the Securities and Exchange
Commission, including the Form 10-K for the year ended Dec. 31, 2004,
may cause actual results or events to differ materially from those
described in the forward-looking statements in this press release.